Genmab nominates Eli Lilly veteran as board member

Genmab has nominated a successor to Jonathan Peacock, who stepped down from the company’s board of directors last year. The appointee is a woman with more than 24 years of experience at Eli Lilly.
Photo: Joost Melis / Genmab / PR
Photo: Joost Melis / Genmab / PR
by marketwire, translated by daniel pedersen

Genmab proposes Elizabeth O’Farrell be elected as a member of the board of directors at the company’s upcoming annual general meeting on March 29, a press release announces.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading